Adaptimmune Therapeutics Plc ADR [ADAP] stock Initiated by H.C. Wainwright analyst, price target now $4
Adaptimmune Therapeutics Plc ADR [NASDAQ: ADAP] loss -23.28% or -0.18 points to close at $0.59 with a heavy trading volume of 14501637 shares. The daily chart for ADAP points out that the company has recorded -50.73% loss over the past six months. If we look